Page 102 - NobleCon20-Book-Project

Health Care
Date November 19, 2024 Health Care
52wk High $30.86
52wk Low $0.90 Jaguar Health, Inc. JAGX $0.98
200 Pine Street
San Francisco, CA 94104

(USD - in millions) jaguar.health
Market Cap 8.9
Enterprise 31.8
Basic Shares Out. 9.24 COMPANY OVERVIEW
Float 8.10
Institutional Holdings 2.86% Detailed Analysis:Channelchek.com
Short Interest 0.33
Avg. 90-Day Volume 0.29 Jaguar Health is a commercial-stage pharmaceutical company focused
on developing novel proprietary prescription medicines sustainably
derived from plants from rainforest areas for people and animals with
gastrointestinal distress, specifically associated with overactive bowel,
EPS Data which includes symptoms such as chronic debilitating diarrhea,
urgency, and bowel incontinence.
2022 2023 2024
CQ1 (1,800.00) (143.40) (3.60)
CQ2 (540.00) (41.40) (4.04)

CQ3 (540.00) (22.80) (1.05)
CQ4 (315.00) N/A (1.67)
CY (2,170.80) (107.40) (0.78) Source: Channelchek/QuoteMedia

Long-Term EPS Estimate N/A
Price/Book (mrq) 1.31
ROE (ttm) -450.92
Debt-to-Total Cap. (mrq) 68.74
Fiscal Year End 31-Dec
200 Pine StreeSan FranciscoCA 94104

Key Executives
CEO: Conte, Lisa
CFO: Lizak, Carol
COO: N/A
IR: Hodge, Peter
Noble Capital Markets, Inc.
Source: Capital IQ, Noble Financial estimates, company filings
Noble Senior Analyst 561-994-1191 noblecapitalmarkets.com
Robert LeBoyer MEMBERS: FINRA, SIPC, MSRB
Following the conference, complete video library of presentations will be
rleboyer@noblelsp.com available at: channelchek.com | nobleconference.com
(212) 896-4625

Refer to the back of the book for disclosures